矩阵效应与微生物新陈代谢之间的相互作用对联素生物利用性的重要性
Susana Langa1, José Antonio Curiel1, Ruiz de la Bastida1
1Departamento de Tecnología de Alimentos, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA-CSIC), Madrid, Spain.
Journal of the science of food and agriculture
|November 18, 2025
概括
减少对植物基素的矩阵效应显著增加了它们被肠道微生物转化为基素的转化. 这提高了素的生物可访问性和生物可用性,改善了它们的健康益处.
科学领域:
- 微生物学 微生物学
- 营养科学 营养科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 植物类是具有有限生物可用性和生物活性的多.
- 肠道微生物群将植物质素转化为质素.
- 饮食摄入量和食物矩阵影响着素代谢.
研究的目的:
- 为了研究食物矩阵如何影响肠道微生物群的灵代谢.
- 为了确定增强素生物可访问性是否会提高它们的生物可用性.
主要方法:
- 用人类便样本化林.
- 由Bifidobacterium pseudocatenulatum发酵的素丰富的食物.
- 在小鼠中分析甲酸生产和血/肝脏度.
主要成果:
- 人类便样本显示,与亚麻提取物相比,secoisolariciresinol产生的肠乳 (ENL) 产量显著增加.
- 乳 (ENL) 主要由二-ENL (DHENL) 通过-ENL (HENL) 生产.
- 用Bifidobacterium pseudocatenulatum发酵在小鼠中增加了干素度,DHENL,HENL和ENL具有最高的生物利用性.
结论:
- 食物矩阵显著影响着干素的生物可访问性和微生物转化为干素.
- 降低矩阵效应可以增强甲酸的产生,并增加摄入的甲酸的生物可用性.
- 这项研究突出了食物矩阵在优化林格南的健康潜力的重要性.
相关概念视频
Bioavailability: Influencing Factors
320
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
320
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
481
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
481
Factors Affecting Drug Biotransformation: Biological
501
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
501
Factors Influencing Bioavailability: First-Pass Elimination
7.9K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
7.9K
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
692
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
692
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
185
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
185


